Unterehmen auf Watchlist setzen
Acer Therapeutics
ISIN: US00444P1084
WKN:
Curious about what AI knows about Acer Therapeutics? Just one click more
More AI Integrations
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Acer Therapeutics · ISIN: US00444P1084 · PR Newswire (ID: 20230906NY01456)
06 September 2023 06:31AM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER


NEW YORK, Sept. 6, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Thorne HealthTech, Inc. (NASDAQ: THRN)'s sale to L Catterton for $10.20 per share in cash. If you are a Thorne shareholder, click here to learn more about your rights and options.  

Abcam plc (NASDAQ: ABCM)'s sale to Danaher Corporation for $24.00 per share in cash. If you are an Abcam shareholder, click here to learn more about your rights and options.  

AgeX Therapeutics, Inc. (NYSE: AGE)'s merger with Serina Therapeutics, Inc. Upon completion of the merger, pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company. If you are an AgeX shareholder, click here to learn more about your rights and options.

Acer Therapeutics Inc. (NASDAQ: ACER)'s sale to Zevra Therapeutics, Inc. for 0.121 of a share of Zevra's common stock for each share of Acer's common stock. Additionally, Acer stockholders would receive non-transferable Contingent Value Rights entitling them to receive up to $34 million in cash upon the achievement of certain commercial milestones for OLPRUVA, and up to an additional $42 million in cash upon the achievement of certain regulatory milestones for OLPRUVA and EDSIVO. If you are an Acer shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-thrn-abcm-age-acer-301918570.html

SOURCE Halper Sadeh LLP

Visuelle Wertentwicklung / Kursverlauf · Acer Therapeutics
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
MIC: XNAS
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942